Trefoil Therapeutics Raises $28 Million Series A to Advance Engineered FGF-1 for the Treatment of Corneal Diseases
July 16, 2019 07:30 ET
|
Trefoil Therapeutics
Lead candidate TTHX1114 will advance to IND and clinical study in corneal endothelial disease in early 2020 SAN DIEGO, July 16, 2019 (GLOBE NEWSWIRE) -- Trefoil Therapeutics announced it raised $28...